GFAP and central nervous system cancer: In the transgenic mice presented here, we have diagnosed the lesions as resembling human anaplastic oligoastrocytomas WHO grade III because the neoplastic areas had a marked Gfap+ astrocytic component, showed a diffuse growth pattern and was accompanied by vascular proliferations, similar to WHO grade III human gliomas.